| Q1 FY27 | Jul 31, 2026 | 80,667 | +19.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY26 | Apr 30, 2026 | 85,699 | +55.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY26 | Jan 31, 2026 | 68,641 | +9.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY26 | Oct 31, 2025 | 83,877 | +48.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY26 | Jul 31, 2025 | 67,412 | +19.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY25 | Apr 30, 2025 | 55,064 | +4.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY25 | Jan 31, 2025 | 62,864 | +6.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY25 | Oct 31, 2024 | 56,506 | -6.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY25 | Jul 31, 2024 | 56,661 | +9.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY24 | Apr 30, 2024 | 52,655 | -13.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY24 | Jan 31, 2024 | 58,931 | -24.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY24 | Oct 31, 2023 | 60,146 | +17.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY24 | Jul 31, 2023 | 51,670 | -57.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY23 | Apr 30, 2023 | 60,887 | -21.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY23 | Jan 31, 2023 | 78,398 | +129.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY23 | Oct 31, 2022 | 51,037 | +29.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY23 | Jul 31, 2022 | 122,109 | +233.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY22 | Apr 30, 2022 | 77,600 | +118.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY22 | Jan 31, 2022 | 34,201 | -4.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY22 | Oct 31, 2021 | 39,456 | -13.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY22 | Jul 31, 2021 | 36,660 | -17.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY21 | Apr 30, 2021 | 35,588 | -24.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY21 | Jan 31, 2021 | 35,742 | -16.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY21 | Oct 31, 2020 | 45,424 | -2.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY21 | Jul 31, 2020 | 44,500 | -1.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY20 | Apr 30, 2020 | 47,332 | +11.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY20 | Jan 31, 2020 | 42,684 | +12.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY20 | Oct 31, 2019 | 46,469 | +7.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY20 | Jul 31, 2019 | 45,075 | +51.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY19 | Apr 30, 2019 | 42,638 | +82.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY19 | Jan 31, 2019 | 37,851 | +73.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY19 | Oct 31, 2018 | 43,208 | +49.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY19 | Jul 31, 2018 | 29,672 | -28.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY18 | Apr 30, 2018 | 23,324 | -40.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY18 | Jan 31, 2018 | 21,880 | -6.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY18 | Oct 31, 2017 | 28,884 | -12.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY18 | Jul 31, 2017 | 41,608 | +120.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY17 | Apr 30, 2017 | 39,436 | +131.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY17 | Jan 31, 2017 | 23,466 | +7.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY17 | Oct 31, 2016 | 33,158 | -5.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY17 | Jul 31, 2016 | 18,889 | -45.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY16 | Apr 30, 2016 | 17,068 | -43.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY16 | Jan 31, 2016 | 21,754 | -41.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY16 | Oct 31, 2015 | 34,980 | -21.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY16 | Jul 31, 2015 | 34,417 | +284.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY15 | Apr 30, 2015 | 29,998 | +294.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY15 | Jan 31, 2015 | 37,178 | +1,948.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY15 | Oct 31, 2014 | 44,269 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY15 | Jul 31, 2014 | 8,943 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY14 | Apr 30, 2014 | 7,598 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY14 | Jan 31, 2014 | 1,815 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|